Price $23.17 |
Market Cap
133.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
9.5
|
P/B
1.06
|
P/S
1.49
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
9.3
|
Op. Cash Flow
20K
|
FCF
2.0
|
|
Op. Margin
23.90%
|
Net Margin
15.80%
|
ROE
11.80%
|
ROI
17.30%
|
|
ROA
9.30%
|
EPS Growth
-27.30%
|
Current Ratio
6.0
|
Debt/Equity
0.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Qiagen NV (QGEN) | $43.02 | - | - | 9.62B | Strong Buy |
| Champions Oncology Inc (CSBR) | $9.48 | - | - | 91.8M | Strong Buy |
| Digirad Corporation (DRAD) | $2.23 | - | - | 6.7M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $12.91 | - | - | 12.02B | Strong Buy |
| MTBC Inc (MTBC) | $6.33 | - | - | 76.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
